These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28545455)

  • 1. The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphism.
    Moradi M; Mahmoudi M; Saedisomeolia A; Zahirihashemi R; Koohdani F
    Nutr J; 2017 May; 16(1):34. PubMed ID: 28545455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the relationship between APOA-II -265T>C polymorphism and HDL function in response to weight loss in overweight and obese type 2 diabetic patients.
    Moradi M; Mahmoudi M; Saedisomeolia A; Mansournia MA; Zahirihashemi R; Koohdani F
    Clin Nutr; 2018 Jun; 37(3):965-969. PubMed ID: 28457653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between ApoA-II -265T/C polymorphism and oxidative stress in patients with type 2 diabetes mellitus.
    Koohdani F; Sadrzadeh-Yeganeh H; Djalali M; Eshraghian M; Keramat L; Mansournia MA; Zamani E
    J Diabetes Complications; 2015; 29(7):908-12. PubMed ID: 26104730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOA II genotypes frequency and their interaction with saturated fatty acids consumption on lipid profile of patients with type 2 diabetes.
    Noorshahi N; Sotoudeh G; Djalali M; Eshraghian MR; Keramatipour M; Basiri MG; Doostan F; Koohdani F
    Clin Nutr; 2016 Aug; 35(4):907-11. PubMed ID: 26210798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity.
    Vohl MC; Lamarche B; Bergeron J; Moorjani S; Prud'homme D; Nadeau A; Tremblay A; Lupien PJ; Bouchard C; Després JP
    Atherosclerosis; 1997 Feb; 128(2):183-90. PubMed ID: 9050775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lecithin: cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels.
    Agirbasli D; Cirakoglu B; Eren F; Sumerkan M; Aksoy S; Aral C; Agirbasli M
    J Clin Lipidol; 2011; 5(3):152-158. PubMed ID: 21600519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA polymorphism for LCAT is associated with altered LCAT activity and high density lipoprotein size distributions in baboons.
    Rainwater DL; Blangero J; Hixson JE; Birnbaum S; Mott GE; VandeBerg JL
    Arterioscler Thromb; 1992 Jun; 12(6):682-90. PubMed ID: 1350465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking, high-density lipoprotein cholesterol subfractions, and lecithin: cholesterol acyltransferase in young women.
    Imamura H; Teshima K; Miyamoto N; Shirota T
    Metabolism; 2002 Oct; 51(10):1313-6. PubMed ID: 12370852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein-cholesterol, its subfractions, and responses to exercise training are dependent on endothelial lipase genotype.
    Halverstadt A; Phares DA; Ferrell RE; Wilund KR; Goldberg AP; Hagberg JM
    Metabolism; 2003 Nov; 52(11):1505-11. PubMed ID: 14624415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA polymorphism for lecithin:cholesterol acyltransferase (LCAT) is associated with high density lipoprotein cholesterol concentrations in baboons.
    Kammerer CM; Hixson JE; Mott GE
    Atherosclerosis; 1993 Jan; 98(2):153-63. PubMed ID: 8457258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of increasing fruit and vegetable intake and how this influences the carotenoid concentration and activities of PON-1 and LCAT in HDL from subjects with type 2 diabetes.
    Daniels JA; Mulligan C; McCance D; Woodside JV; Patterson C; Young IS; McEneny J
    Cardiovasc Diabetol; 2014 Jan; 13():16. PubMed ID: 24423117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of two apolipoprotein A-I gene MspI polymorphisms with high density lipoprotein (HDL)-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early-onset type 2 diabetes.
    Ma YQ; Thomas GN; Ng MC; Critchley JA; Cockram CS; Chan JC; Tomlinson B
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):442-9. PubMed ID: 14510906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial.
    Pammer A; Obermayer A; Stadler JT; Pferschy PN; Tripolt NJ; Habisch H; Madl T; Sourij H; Marsche G
    Cardiovasc Diabetol; 2024 Sep; 23(1):339. PubMed ID: 39267053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 360His polymorphism of the apolipoproteinA-IV gene and plasma lipid response to energy restricted diets in overweight subjects.
    Heilbronn LK; Noakes M; Morris AM; Kind KL; Clifton PM
    Atherosclerosis; 2000 May; 150(1):187-92. PubMed ID: 10781650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xmn1 restriction polymorphism of apolipoprotein AI gene and lipoprotein levels in obesity.
    Durack-Bown I; Fumeron F; Betoulle D; Chevreuil O; Apfelbaum M
    Int J Obes Relat Metab Disord; 1994 Jul; 18(7):460-4. PubMed ID: 7920870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects on lipid metabolism of weight reduction on lactovegetarian and mixed diet.
    Marniemi J; Seppänen A; Hakala P
    Int J Obes; 1990 Feb; 14(2):113-25. PubMed ID: 2111292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein J polymorphisms and serum HDL cholesterol levels in African blacks.
    Nestlerode CS; Bunker CH; Sanghera DK; Aston CE; Ukoli FA; Kamboh MI
    Hum Biol; 1999 Apr; 71(2):197-218. PubMed ID: 10222643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in the CLOCK gene may influence the effect of fat intake reduction on weight loss.
    Loria-Kohen V; Espinosa-Salinas I; Marcos-Pasero H; Lourenço-Nogueira T; Herranz J; Molina S; Reglero G; Ramirez de Molina A
    Nutrition; 2016 Apr; 32(4):453-60. PubMed ID: 26690565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre beta 1-high-density lipoprotein increases in coronary artery disease.
    Miida T; Nakamura Y; Inano K; Matsuto T; Yamaguchi T; Tsuda T; Okada M
    Clin Chem; 1996 Dec; 42(12):1992-5. PubMed ID: 8969638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The common -55 C/T polymorphism in the promoter region of the uncoupling protein 3 gene reduces prevalence of obesity and elevates serum high-density lipoprotein cholesterol levels in the general Japanese population.
    Hamada T; Kotani K; Fujiwara S; Sano Y; Domichi M; Tsuzaki K; Sakane N
    Metabolism; 2008 Mar; 57(3):410-5. PubMed ID: 18249216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.